diflunisal has been researched along with Osteomyelitis in 3 studies
Diflunisal: A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN.
diflunisal : An organofluorine compound comprising salicylic acid having a 2,4-difluorophenyl group at the 5-position.
Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteomyelitis is a debilitating infection of bone that results in substantial morbidity." | 5.62 | Diflunisal-loaded poly(propylene sulfide) nanoparticles decrease S. aureus-mediated bone destruction during osteomyelitis. ( Cassat, JE; Duvall, CL; Ford, CA; Guelcher, SA; Gupta, MK; Spoonmore, TJ, 2021) |
| "Diflunisal is known to inhibit S." | 5.43 | Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis. ( Cassat, JE; Guelcher, SA; Hammer, ND; Hendrix, AS; Putnam, NE; Skaar, EP; Snyder, DJ; Spoonmore, TJ; Wilde, AD, 2016) |
| "Osteomyelitis is a debilitating infection of bone that results in substantial morbidity." | 1.62 | Diflunisal-loaded poly(propylene sulfide) nanoparticles decrease S. aureus-mediated bone destruction during osteomyelitis. ( Cassat, JE; Duvall, CL; Ford, CA; Guelcher, SA; Gupta, MK; Spoonmore, TJ, 2021) |
| "Diflunisal is known to inhibit S." | 1.43 | Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis. ( Cassat, JE; Guelcher, SA; Hammer, ND; Hendrix, AS; Putnam, NE; Skaar, EP; Snyder, DJ; Spoonmore, TJ; Wilde, AD, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Spoonmore, TJ | 3 |
| Ford, CA | 2 |
| Curry, JM | 1 |
| Guelcher, SA | 3 |
| Cassat, JE | 3 |
| Gupta, MK | 1 |
| Duvall, CL | 1 |
| Hendrix, AS | 1 |
| Wilde, AD | 1 |
| Putnam, NE | 1 |
| Hammer, ND | 1 |
| Snyder, DJ | 1 |
| Skaar, EP | 1 |
3 other studies available for diflunisal and Osteomyelitis
| Article | Year |
|---|---|
Concurrent Local Delivery of Diflunisal Limits Bone Destruction but Fails To Improve Systemic Vancomycin Efficacy during Staphylococcus aureus Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Diflunisal; Mice; Osteomyelitis; Staphylococcal Infections; Staphylo | 2020 |
Diflunisal-loaded poly(propylene sulfide) nanoparticles decrease S. aureus-mediated bone destruction during osteomyelitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone and Bones; Cell Line; Diflunisal; Drug Delive | 2021 |
Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Proteins; Bone De | 2016 |